| TRIM family proteins: retroviral restriction and antiviral defence S Nisole, JP Stoye, A Saïb Nature Reviews Microbiology 3 (10), 799, 2005 | 717 | 2005 |
| Trim5α protein restricts both HIV-1 and murine leukemia virus MW Yap, S Nisole, C Lynch, JP Stoye Proceedings of the National Academy of Sciences 101 (29), 10786-10791, 2004 | 495 | 2004 |
| A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction MW Yap, S Nisole, JP Stoye Current Biology 15 (1), 73-78, 2005 | 450 | 2005 |
| A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1 S Nisole, C Lynch, JP Stoye, MW Yap Proceedings of the National Academy of Sciences 101 (36), 13324-13328, 2004 | 336 | 2004 |
| Early steps of retrovirus replicative cycle S Nisole, A Saïb Retrovirology 1 (1), 9, 2004 | 280 | 2004 |
| Human TRIM gene expression in response to interferons L Carthagena, A Bergamaschi, JM Luna, A David, PD Uchil, ... PloS one 4 (3), e4894, 2009 | 222 | 2009 |
| The cell-surface-expressed nucleolin is associated with the actin cytoskeleton AG Hovanessian, F Puvion-Dutilleul, S Nisole, J Svab, E Perret, JS Deng, ... Experimental cell research 261 (2), 312-328, 2000 | 217 | 2000 |
| Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype J Dumonceaux, S Nisole, C Chanel, L Quivet, A Amara, F Baleux, ... Journal of virology 72 (1), 512-519, 1998 | 173 | 1998 |
| The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor EA Said, B Krust, S Nisole, J Svab, JP Briand, AG Hovanessian Journal of Biological Chemistry 277 (40), 37492-37502, 2002 | 149 | 2002 |
| The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection A Bergamaschi, D Ayinde, A David, E Le Rouzic, M Morel, G Collin, ... Journal of virology 83 (10), 4854-4860, 2009 | 124 | 2009 |
| Differential roles of PML isoforms S Nisole, MA Maroui, X Mascle, M Aubry, MK Chelbi-Alix Frontiers in oncology 3, 125, 2013 | 94 | 2013 |
| Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains S Nisole, B Krust, AG Hovanessian Experimental cell research 276 (2), 155-173, 2002 | 94 | 2002 |
| The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans S Nisole, B Krust, C Callebaut, G Guichard, S Muller, JP Briand, ... Journal of Biological Chemistry 274 (39), 27875-27884, 1999 | 94 | 1999 |
| The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells S Nisole, EA Said, C Mische, MC Prevost, B Krust, P Bouvet, A Bianco, ... Journal of Biological Chemistry 277 (23), 20877-20886, 2002 | 88 | 2002 |
| Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities L Carthagena, MC Parise, M Ringeard, MK Chelbi-Alix, U Hazan, ... Retrovirology 5 (1), 59, 2008 | 79 | 2008 |
| The CDK inhibitor p21Cip1/WAF1 is induced by FcγR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human … A Bergamaschi, A David, E Le Rouzic, S Nisole, F Barré-Sinoussi, ... Journal of virology 83 (23), 12253-12265, 2009 | 64 | 2009 |
| Inhibition of HIV infection by the cytokine midkine C Callebaut, S Nisole, JP Briand, B Krust, AG Hovanessian Virology 281 (2), 248-264, 2001 | 60 | 2001 |
| Implication of PMLIV in both intrinsic and innate immunity F El Asmi, MA Maroui, J Dutrieux, D Blondel, S Nisole, MK Chelbi-Alix PLoS pathogens 10 (2), e1003975, 2014 | 51 | 2014 |
| Hyperthermia stimulates HIV-1 replication F Roesch, O Meziane, A Kula, S Nisole, F Porrot, I Anderson, F Mammano, ... PLoS pathogens 8 (7), e1002792, 2012 | 44 | 2012 |
| HIV-derived vectors for therapy and vaccination against HIV F Di Nunzio, T Felix, NJ Arhel, S Nisole, P Charneau, AS Beignon Vaccine 30 (15), 2499-2509, 2012 | 30 | 2012 |
